These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38393963)

  • 1. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
    Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
    ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model.
    Li Q; Liu Y; Guo X; Zhang L; Li L; Zhao D; Zhang X; Hong W; Zheng C; Liang B
    Biomed Pharmacother; 2022 Jul; 151():113123. PubMed ID: 35594702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
    Yurdacan B; Egeli U; Guney Eskiler G; Eryilmaz IE; Cecener G; Tunca B
    J Pharm Pharmacol; 2019 Jul; 71(7):1119-1132. PubMed ID: 31025377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment Triggered Cascade-Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma.
    Xin F; Wu M; Cai Z; Zhang X; Wei Z; Liu X; Liu J
    Adv Healthc Mater; 2021 May; 10(10):e2002036. PubMed ID: 33644987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression.
    Wu MH; Chiu YF; Wu WJ; Wu PL; Lin CY; Lin CL; Hsieh YH; Liu CJ
    Environ Toxicol; 2018 Dec; 33(12):1237-1244. PubMed ID: 30187994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
    Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
    Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.
    Lin WH; Yeh SH; Yeh KH; Chen KW; Cheng YW; Su TH; Jao P; Ni LC; Chen PJ; Chen DS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11937-11942. PubMed ID: 27702890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupick√Ĺ D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment.
    Zan Y; Dai Z; Liang L; Deng Y; Dong L
    Drug Deliv; 2019 Dec; 26(1):1080-1091. PubMed ID: 31735093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
    Saraswati S; Alhaider A; Abdelgadir AM; Tanwer P; Korashy HM
    Cell Commun Signal; 2019 Oct; 17(1):127. PubMed ID: 31619257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
    Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
    J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
    Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.